Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Net cash flows from operating activities:
Net (loss) income	$ (12,093)	$ 840
Adjustments to reconcile net (loss) income to net cash from operating activities:
Depreciation and amortization	13,088	10,984
Non-cash compensation	16,578	14,167
Non-cash lease expense	2,612	2,510
Write-down of inventories and deferred preservation costs	2,368	2,379
Deferred income taxes	(1,421)	(231)
Change in fair value of contingent consideration	9,710	(210)
Losses on inducement/extinguishment of debt	0	2,664
Other	(2,590)	(7,423)
Changes in operating assets and liabilities, net of acquisition:
Receivables	(7,971)	(9,660)
Inventories and deferred preservation costs	(10,752)	(5,521)
Prepaid expenses and other assets	(5,271)	(6,215)
Accounts payable, accrued expenses, and other liabilities	(4,370)	(6,226)
Net cash flows used in operating activities	(112)	(1,942)
Net cash flows from investing activities:
Capital expenditures	(18,751)	(6,925)
Acquisition of Endospan, net of cash acquired	(116,661)	0
Payments related to sale of non-financial assets	(1,500)	0
Other	(3,000)	0
Net cash flows used in investing activities	(139,912)	(6,925)
Net cash flows from financing activities:
Proceeds from issuance of long-term debt, net	148,875	0
Repayment of debt	0	(134)
Proceeds from exercise of stock options and issuance of common stock	2,625	4,459
Proceeds from financing insurance premiums	3,217	3,117
Principal payments on short-term notes payable	(1,440)	(554)
Other	(426)	(353)
Net cash flows provided by financing activities	152,851	6,535
Effect of exchange rate changes on cash and cash equivalents	(419)	2,345
Increase in cash and cash equivalents	12,408	13
Cash and cash equivalents beginning of period	64,908	53,463
Cash and cash equivalents end of period	$ 77,316	$ 53,476